These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7772749)

  • 1. Preclinical toxicology study of liposome encapsulated doxorubicin (TLC D-99) given intraperitoneally to dogs.
    Kanter PM; Klaich G; Bullard GA; King JM; Pavelic ZP
    In Vivo; 1994; 8(6):975-82. PubMed ID: 7772749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical toxicology study of liposome encapsulated doxorubicin (TLC D-99): comparison with doxorubicin and empty liposomes in mice and dogs.
    Kanter PM; Bullard GA; Pilkiewicz FG; Mayer LD; Cullis PR; Pavelic ZP
    In Vivo; 1993; 7(1):85-95. PubMed ID: 8504212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the cardiotoxic effects of liposomal doxorubicin (TLC D-99) versus free doxorubicin in beagle dogs.
    Kanter PM; Bullard GA; Ginsberg RA; Pilkiewicz FG; Mayer LD; Cullis PR; Pavelic ZP
    In Vivo; 1993; 7(1):17-26. PubMed ID: 8504204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of chronic doxorubicin cardiotoxicity in beagles by liposomal encapsulation.
    Herman EH; Rahman A; Ferrans VJ; Vick JA; Schein PS
    Cancer Res; 1983 Nov; 43(11):5427-32. PubMed ID: 6616474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial clinical (phase I) trial of TLC D-99 (doxorubicin encapsulated in liposomes).
    Cowens JW; Creaven PJ; Greco WR; Brenner DE; Tung Y; Ostro M; Pilkiewicz F; Ginsberg R; Petrelli N
    Cancer Res; 1993 Jun; 53(12):2796-802. PubMed ID: 8504422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical toxicity of liposome-incorporated annamycin: selective bone marrow toxicity with lack of cardiotoxicity.
    Zou Y; Priebe W; Stephens LC; Perez-Soler R
    Clin Cancer Res; 1995 Nov; 1(11):1369-74. PubMed ID: 9815933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I and pharmacokinetic study of a stable, polyethylene-glycolated liposomal doxorubicin in patients with solid tumors: the relation between pharmacokinetic property and toxicity.
    Hong RL; Tseng YL
    Cancer; 2001 May; 91(9):1826-33. PubMed ID: 11335910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposomal doxorubicin (Caelyx) in advanced pretreated soft tissue sarcomas: a phase II study of the Italian Sarcoma Group (ISG).
    Toma S; Tucci A; Villani G; Carteni G; Spadini N; Palumbo R
    Anticancer Res; 2000; 20(1B):485-91. PubMed ID: 10769710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of intraperitoneal administration of free and liposome-entrapped doxorubicin on rat peritoneal exudate cell populations.
    Storm G; Steerenberg PA; Van Borssum Waalkes M; Crommelin DJ
    J Drug Target; 1996; 4(4):255-64. PubMed ID: 9010815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase I trial of prolonged oral etoposide and liposomal doxorubicin in ovarian, peritoneal, and tubal carcinoma: a gynecologic oncology group study.
    Rose PG; Rodriguez M; Walker J; Greer B; Fusco N; McGuire W
    Gynecol Oncol; 2002 Apr; 85(1):136-9. PubMed ID: 11925133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative long-term study of the toxicities of free and liposome-associated doxorubicin in mice after intravenous administration.
    Gabizon A; Meshorer A; Barenholz Y
    J Natl Cancer Inst; 1986 Aug; 77(2):459-69. PubMed ID: 3461207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The liposomal formulation of doxorubicin.
    Abraham SA; Waterhouse DN; Mayer LD; Cullis PR; Madden TD; Bally MB
    Methods Enzymol; 2005; 391():71-97. PubMed ID: 15721375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of the cardiotoxicity of doxorubicin in rabbits and dogs by encapsulation in long-circulating, pegylated liposomes.
    Working PK; Newman MS; Sullivan T; Yarrington J
    J Pharmacol Exp Ther; 1999 May; 289(2):1128-33. PubMed ID: 10215696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase 1 clinical study of pegylated liposomal doxorubicin (JNS002) in Japanese patients with solid tumors.
    Fujisaka Y; Horiike A; Shimizu T; Yamamoto N; Yamada Y; Tamura T
    Jpn J Clin Oncol; 2006 Dec; 36(12):768-74. PubMed ID: 17095524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AIDS-related Kaposi's sarcoma: a phase II study of liposomal doxorubicin. The TLC D-99 Study Group.
    Cheung TW; Remick SC; Azarnia N; Proper JA; Barrueco JR; Dezube BJ
    Clin Cancer Res; 1999 Nov; 5(11):3432-7. PubMed ID: 10589755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paclitaxel, carboplatin and pegylated liposomal doxorubicin in ovarian and peritoneal carcinoma: a phase I study of the Gynecologic Oncology Group.
    Rose PG; Greer BE; Horowitz IR; Markman M; Fusco N
    Gynecol Oncol; 2007 Jan; 104(1):114-9. PubMed ID: 16959305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposomal doxorubicin in ovarian, peritoneal, and tubal carcinoma: a retrospective comparative study of single-agent dosages.
    Rose PG; Maxson JH; Fusco N; Mossbruger K; Rodriguez M
    Gynecol Oncol; 2001 Aug; 82(2):323-8. PubMed ID: 11531287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of the antitumor activity of free doxorubicin and polyethylene glycol-coated liposomal doxorubicin in a mouse lymphoma model.
    Cabanes A; Tzemach D; Goren D; Horowitz AT; Gabizon A
    Clin Cancer Res; 1998 Feb; 4(2):499-505. PubMed ID: 9516942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accumulation of liposomal lipid and encapsulated doxorubicin in murine Lewis lung carcinoma: the lack of beneficial effects by coating liposomes with poly(ethylene glycol).
    Parr MJ; Masin D; Cullis PR; Bally MB
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1319-27. PubMed ID: 9067319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II trial of liposomal doxorubicin at 40 mg/m(2) every 4 weeks in endometrial carcinoma: a Gynecologic Oncology Group Study.
    Homesley HD; Blessing JA; Sorosky J; Reid G; Look KY
    Gynecol Oncol; 2005 Aug; 98(2):294-8. PubMed ID: 15975638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.